Exelixis Inc. (NASDAQ:EXEL) saw a downside of -1.25% to close Tuesday at $21.40 after subtracting -$0.27 on the day. The 5-day average trading volume is 1,536,740 shares of the company’s common stock. It has gained $22.00 in the past week. An average of 1,623,560 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 1,958,700.
EXEL’s 1-month performance is 5.84% or $1.44 on its low of $19.62 reached on 09/20/21. The company’s shares have touched a 52-week low of $16.19 and high of $25.77, with the stock’s rally to the 52-week high happening on 05/14/21. YTD, EXEL has achieved 6.63% or $1.33. However, the current price is down -16.96%% from the 52-week high price.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
On Sep 16, 27 days have gone by since the last insider trading activity for Exelixis Inc. (EXEL). Haley Patrick J. (EVP, Commercial) most recently sold 25,000 shares at $20.36 per share on Sep 16. This transaction cost the insider $509,000. EVP, Scientific Strategy & CSO, Lamb Peter, sold 47,500 shares at a price of $20.46 on Sep 15. Then, on Aug 16, EVP, Scientific Strategy & CSO Lamb Peter sold 55,000 shares at a price of $18.44 per share. This transaction amounted to $1,014,200.
The company’s PE ratio for the last five years has touched a high of 153.89 and a low of 7.769. EXEL stock has a beta of 0.95. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 5.81 while the price-to-book (PB) in the most recent quarter is 3.29, with the price to cash flow ratio at 30.83.
Exelixis Inc.’s quick ratio for the period ended June 29 was 6.10, with the current ratio over the same period at 6.20 meaning that EXEL stock is able to fulfill its debt obligations. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.00, while the total debt to equity was 0.00. In terms of profitability, the gross margin trailing 12 months is 96.00%. The trailing 12-month EBITDA margin is 12.56% while for the period ending June 29; Exelixis Inc.’s operating margin was 8.70%. The firm’s gross profit as reported stood at $951.27 million against revenue of $987.54 million.
For the quarterly period ending June 29 this year, Exelixis Inc.’s cash and short-term investments amounted to $854.17 million against total debt of $53.22 million. Net income and sales went up compared to those figures reported in the previous quarter. Analysts expected EXEL to announce $0.06 per share in earnings in its latest quarter, but it posted $0.3, representing a 400.00% surprise. EBITDA for the quarter stood at more than $126.68 million. EXEL stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 324.19 million, with total debt at $53.22 million. Shareholders hold equity totaling $315.05 million
Let’s look briefly at Exelixis Inc. (EXEL) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 12 October was 60.77% to suggest the stock is trending Neutral, with historical volatility in this time period at 26.31%.
The stock’s 5-day moving average is $21.43, reflecting a +2.34% or $0.49 change from its current price. EXEL is currently trading +6.31% above its 20-day SMA, -12.04% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by +24.20% and +3.33% respectively.
Stochastic %K and %D was 82.02% and 84.26% and the average true range (ATR) pointed at 0.56. The RSI (14) points at 61.23%, while the 14-day stochastic is at 66.85% with the period’s ATR at 0.57. The stock’s 9-day MACD Oscillator is pointing at 0.25 and 0.52 on the 14-day charts.
In the most recent analyst report for Exelixis Inc. (NASDAQ: EXEL), Jefferies launched coverage with a Buy rating. Analysts offering their rating for EXEL stock have a consensus rating for the stock as Overweight. Currently, 1 brokerage advisors rate EXEL as a “sell,”, while 2 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 1 rates the stock as overweight while 10 have offered a “buy” rating.
What is EXEL’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $21.00 and a high of $65.00, with their median price target at $30.00. Looking at these predictions, the average price target given by analysts is for Exelixis Inc. (EXEL) stock is $31.54.